Short-course IV or oral antibiotics may match longer regimens for pediatric bone and joint infections
Short Antibiotic Courses May Work for Children With Bone Infections
This meta-analysis of 6 studies (813 children) found no significant difference in treatment success between short-course intravenous therapy…
Short-course intravenous antibiotics or oral treatments may be as effective as longer IV treatments for children with uncomplicated bone and…
Loneliness affects 46.9% of people with HIV, social isolation 25.9%
Loneliness and Isolation Common in People with HIV
This meta-analysis of 66 studies finds that loneliness and social isolation are highly prevalent among people living with HIV, with pooled p…
A new meta-analysis finds that nearly half of people with HIV experience loneliness, and about a quarter face social isolation.
Inhaled antibiotics may improve lung function and microbiological eradication in cystic fibrosis and bronchiectasis
Inhaled Antibiotics May Improve Lung Health in Chronic Lung Conditions
This meta-analysis evaluated the efficacy of inhaled antibiotics for patients with cystic fibrosis, non-cystic fibrosis bronchiectasis, and …
Inhaled antibiotics may improve lung function and clear infections for people with cystic fibrosis and other chronic lung conditions.
Pseudomonas aeruginosa in Africa shows 54.4% pooled antibiotic resistance, 100% to tetracyclines
Bacteria in Africa Show Full Resistance to Tetracyclines and Glycylcyclines
This meta-analysis of 28 studies from 13 African countries found a pooled Pseudomonas aeruginosa resistance rate of 54.4% across antibiotic …
A review of 28 studies across 13 African countries shows that Pseudomonas aeruginosa bacteria show 100% resistance to specific antibiotics.
Antibiotic residues found in 42.6% of chicken products across Africa, meta-analysis reports
Antibiotic Residues Found in African Chicken Products and Eggs
This meta-analysis of 52 sample-specific datasets from 39 articles estimates that 42.60% of chicken products in Africa contain antibiotic re…
A review of 52 datasets shows that over 40% of chicken products in Africa contain traces of antibiotics like doxycycline and oxytetracycline…
Oral topoisomerase II inhibitors show no significant difference from ceftriaxone for uncomplicated gonorrhoea
Oral Topoisomerase Inhibitors Show Promise for Treating Gonorrhoea
This meta-analysis evaluates oral type II topoisomerase inhibitors, including gepidacin and zoliflodacin, compared to ceftriaxone-based ther…
New oral medications like gepidacin and zoliflodacin show similar success rates to ceftriaxone for treating uncomplicated gonorrhoea.
FDA Approves Cefazolin in Dextrose Injection for Multiple Infections and Perioperative Prophylaxis
FDA approves Cefazolin in Dextrose for infections and surgery prevention.
The FDA has approved Cefazolin in Dextrose Injection for the treatment of various infections and for perioperative prophylaxis in certain pa…
The FDA approved Cefazolin in Dextrose Injection to treat various bacterial infections and to prevent infections during surgery. It is for a…
FDA Approves Oxacillin Injection for Penicillinase-Producing Staphylococcal Infections
FDA approves Bactocill for certain staph infections in hospitals
The FDA has approved oxacillin injection for treating infections caused by penicillinase-producing staphylococci susceptible to the drug. It…
The FDA approved Bactocill (oxacillin) to treat infections caused by certain staph bacteria. This medicine is given intravenously in a hospi…
Antibiotic exposure disrupts gut microbiota in 58% to 94% of critically ill children
Antibiotics and gut health in critically ill children
This narrative review examines antibiotic exposure in critically ill children in the PICU, reporting that 58% to 94% receive antibiotics, wh…
Common antibiotics used in intensive care can disrupt a child's gut health, increasing the risk of serious infections like pneumonia.
Evaluation of Once-Weekly Islatravir and Lenacapavir for Chronic HIV-1 Management
Trial shows once-weekly pill may match daily HIV treatment
A Phase 3 trial demonstrates that a once-weekly islatravir-lenacapavir regimen maintains viral suppression comparable to daily standard-of-c…
A new once-weekly pill could offer a simpler way to manage HIV, showing similar success to daily pills in a recent clinical trial.
FDA Approves Tivicay PD (dolutegravir) for Pediatric HIV-1 Infection
FDA approves new HIV drug for children as young as 4 weeks
The FDA approved Tivicay PD (dolutegravir) tablets for oral suspension for the treatment of HIV-1 infection in pediatric patients aged at le…
The FDA approved Tivicay PD, a new liquid form of the HIV drug dolutegravir, for children aged at least 4 weeks and weighing at least 3 kg. …
FDA Approves Tivicay (dolutegravir) for HIV-1 Infection in Adults and Pediatric Patients
FDA approves new HIV drug Tivicay for adults and children
The FDA approved Tivicay (dolutegravir) for the treatment of HIV-1 infection in combination with other antiretroviral agents in adults and p…
The FDA has approved Tivicay (dolutegravir) to treat HIV-1 infection in adults and children. It is used with other HIV medicines. This appro…